Member Info for GloriaMarket

They even argue amongst themselves. Caravan will have departed before EOD leaving stragglers behind.

" as little as 150 days for news "

Mr BigHammer, the new posters will be gone by the weekend. Only stragglers and LTH will be left.

It's been a long wait. Welcome one and all,

please don't sell tomorrow... please...

Great news that another 300k will be drawdown, that not only gives GDR another 3 weeks but also implies that drawdowns will continue unabated until the drawdown facility is exhausted (did someone say that would be in august?).

Easter bunny arrived with treats. Good for the long suffering lths.

Provisional Schedule

Diagnostics consultation: 2 03 April 2024 - 26 April 2024

Expected publication 10 July 2024

"Wishful thinking now, what's the chances of this getting up to 40p this year?"

depends on the interest of the person who answers this question. Those already invested in GDR (ie sitting on losses unless they bought in last week at 2.75p or something) would say there is a reasonable to great chance of sp hitting 40p. Those not invested in GDR (ie the smart money) would say something like "unlikely, as bankrupcy is looming unless RF continue drawdowns (forcing the SP further south) or a share diluation takes place (forcing the SP south)." . I may be wrong though. GLA.

"The fact is many expected Armageddon"

GDR have 9 weeks to dilute the shares through either more drawdowns with RF or a new deal simply to avoid going bust.

"So not everyone agrees…"

Indeed Mr Stockpick, it's truly remarkable. But I suppose that's the human condition - some people voted for Johnson, some poeple think the earth is flat and to quote the comedian Fern Brady, "have you met some people?".

" the time to get in is AFTER the funding is announced, not before."

genius.

I predicted to myself a placing at 1-2p about 9 months ago but I suspect now that a placing @ 1-2p is woefully optimistic (many people tell me I'm always too optimistic). In order to get the millions Mr Cheek rightly fully desires for GDR (18-24 months of funding for growth not just operational costs), I suspect the nominal value of each share will be changed eg 3p become 300p and this will be followed by a large dilution to raise £10M or similar.

Another question I'd really like to know the answer to is how did heavily invested PI's acquire their wealth before they piled in to GDR?

". So why is anyone buying this share today?"

exactly what I was thinking.

. Round is a word to describe something as roughly spherical ie a round ball. But I think you may have helped answer a question that I can't answer.

Who on earth would take a punt on GDR knowing large share dilution(s) in whatever form are required before the end of May?

Perhaps the problem many investors have when they read RNSes is that their attention to detail is misplaced or they focus on the least important information. Todays RNS contained an awful lot of 'ifs', the majority of which involved dates later than the end of May 2024, a date when crucially, the money runs out ( unless further dilutions take place, be it RF's trickle of 300k or a major share dilution - which the CEO has stated he really wants).

Thumbs up if you agree.

"Price being held back all the time ...WHY...!!"

It's the sellers ie RF.

"I got some under 3p...looking like this may even push up today! ;)"

you might be one of handful of new PI's not sitting on a paper loss. Congratulations!

"The business is MOVING into commercialization."

That's like stating the earth is round.

They can't sell their products don't sell, whatever the reason. On the plus side they saw revenue of 240k in 6 months. I would love to know where that came from. Sales? if so, how much cam from brighton and sussex trust?

The crux of the RNS is and always has been funding due to lack of sales.

"Revenue and other income in the period was £0.24m (H1 2022/3: £0.02m)."

"At the current burn rate, the Company has a cash runway through May 2024."

"We are confident that we will continue to gain commercial traction and securing significant revenues, but due to the time required to achieve this, as we have already stated, we will require additional funding. As described in the accounting policies, we continue to adopt a going concern basis for the preparation of the accounts, but the above condition represents a material uncertainty that may cast significant doubt on the Group and Company's ability to continue as a going concern. As set out above, the Company is actively pursuing further equity funding to provide the necessary resources to execute the Company's growth strategy.

Our equity funding plans are being advanced and the intention will be to raise sufficient funding to complete the clinical trials and regulatory approval process in the USA for the AIHL test whilst also providing sufficient funding to cover the Company's operating costs for an appropriate period of time. The Board intends to provide a mechanism for retail shareholders to participate in any equity financing and a further announcement will be made in due course.

Securing further funding is key to the execution of our strategy as is finalising our partnership in the USA for MT-RNR1 studies required for future de novo submission route for FDA approval.

Mr Cheek needs to have contracts up his sleeve for the RNS tomorrow. He just might have. Fingers crossed. GLA.